PhenomeX - Stock

PhenomeX ROCE 2024

PhenomeX ROCE

-0.67

Ticker

CELL

ISIN

US0843101017

WKN

A2P9RR

In 2024, PhenomeX's return on capital employed (ROCE) was -0.67, a 95.77% increase from the -0.34 ROCE in the previous year.

PhenomeX Aktienanalyse

What does PhenomeX do?

The company Berkeley Lights Inc. (BLI) is a biotech startup that was founded in 2011 by Eric Hobbs and Igor Khandros in California. They both had experience in the semiconductor electronics field and decided to utilize their skills to develop a new technology that allows researchers to quickly and efficiently investigate cell-specific processes. The concept behind BLI is based on a novel technology called the "Beacon system." Cells are held on thousands of tiny microchips and can be selectively manipulated using beams of light. The Beacon system enables researchers to isolate, analyze, and select cells rapidly and efficiently, significantly speeding up and simplifying the research process. BLI's business model can be described as B2B, as the company sells its technology and services to other companies in the biotech industry. BLI has two different divisions in which it utilizes its technology and expertise: the "OptoSelect" program and the "Beacon Discovery" program. BLI's OptoSelect program offers customers the ability to select precise and specific cell lines from a large array of cultures. BLI utilizes its Beacon technology to quickly and efficiently isolate and select cells, saving valuable time and resources for researchers. These cell lines can then be used in the development of drugs and therapies, increasing the chances of successful market introduction. BLI's Beacon Discovery program is focused on accelerating the discovery process of new drugs and therapies. BLI works closely with its customers to expedite the drug development process. By using the Beacon technology, it is possible to identify and test potential drug candidates more quickly, significantly reducing the development time. BLI also offers a range of products based on the Beacon technology. These include devices such as the Lightning™ Digital Array, a system for multi-omics analysis of gene expression, immune response, and cell cycle; the Beacon® Controller, a system for controlling the Beacon® microchip platform; and the Beacon® Pak for consumables. Since its founding, BLI has conducted multiple funding rounds and raised over $180 million for the development of its technology and services. The company has established strong partnerships with leading companies in the biotech industry and collaborates closely with researchers and universities to advance its technology. Overall, BLI has established itself as a leading provider of biotech technologies. Through the use of its Beacon technology, the company has accelerated and simplified the process of cell analysis and selection, speeding up the development of new drugs and therapies and increasing the chances of successful market introduction. With its state-of-the-art products and services, BLI is well-positioned to continue playing a significant role in the biotech industry in the future. PhenomeX ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling PhenomeX's Return on Capital Employed (ROCE)

PhenomeX's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing PhenomeX's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

PhenomeX's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in PhenomeX’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about PhenomeX Stock

What is the ROCE (Return on Capital Employed) of PhenomeX this year?

The ROCE of PhenomeX is -0.67 undefined this year.

How has the ROCE (Return on Capital Employed) of PhenomeX developed compared to the previous year?

The ROCE of PhenomeX has increased by 95.77% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of PhenomeX?

A high Return on Capital Employed (ROCE) indicates that PhenomeX has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of PhenomeX?

A low ROCE (Return on Capital Employed) can indicate that PhenomeX has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from PhenomeX impact the company?

An increase in the ROCE of PhenomeX can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of PhenomeX affect the company?

A decrease in ROCE of PhenomeX can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of PhenomeX?

Some factors that can affect PhenomeX's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of PhenomeX so important for investors?

The ROCE of PhenomeX is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can PhenomeX take to improve the ROCE?

To improve the ROCE, PhenomeX can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does PhenomeX pay?

Over the past 12 months, PhenomeX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PhenomeX is expected to pay a dividend of 0 USD.

What is the dividend yield of PhenomeX?

The current dividend yield of PhenomeX is .

When does PhenomeX pay dividends?

PhenomeX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PhenomeX?

PhenomeX paid dividends every year for the past 0 years.

What is the dividend of PhenomeX?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PhenomeX located?

PhenomeX is assigned to the 'Health' sector.

Wann musste ich die Aktien von PhenomeX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PhenomeX from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did PhenomeX pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of PhenomeX in the year 2023?

In the year 2023, PhenomeX distributed 0 USD as dividends.

In which currency does PhenomeX pay out the dividend?

The dividends of PhenomeX are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PhenomeX

Our stock analysis for PhenomeX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PhenomeX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.